Depo-provera:  clinical evaluation.
Mukherjea
M
M
D001208:Asia; D001835:Body Weight; D003267:Contraception; D003268:Contraception Behavior; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003906:Developing Countries; D004194:Disease; D004717:Endometrium; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006805:Human Experimentation; D007194:India; D007267:Injections; D017258:Medroxyprogesterone Acetate; D008599:Menstruation Disturbances; D010342:Patient Acceptance of Health Care; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate
Asia; Body Weight; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Usage; Depo-provera; Developing Countries; Diseases; Endometrial Effects; Evaluation; Evaluation Methodology; Evaluation Research; Family Planning; Human Volunteers; India; Injectables; Medroxyprogesterone Acetate; Menstruation Disorders; Method Acceptability; Research Methodology; Southern Asia